<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190114042354N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-06-23</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of bone quality after lateral sinus lift surgery</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of radiological and histologic bone quality after lateral sinus lift surgery using PRF and allograft: Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43860</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In our study randomization takes place using Randomization.com website and using a random number that insert in pocket. Patients divide into two groups (test and control) based on odd random number that is in the pocket, Blinding description: In this study because our intervention included blood sampling from patients in one group and no sampling in the other group, we are not capable to blind the surgeon and patients, so in our study data analyzer and outcome assessor will be kept blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Bone evaluation after sinus lift surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: open sinus lift surgery using allograft in combination of Platelet rich fibrin.  All surgery was performed with local anaesthesia, and the sinus floor augmentation using lateral window approach.  after a buccal mucoperiosteal flap was raised, an osteotomy was prepared in the lateral wall of the maxillary sinus. After the Schneiderian membrane was carefully elevated, the grafting material was packed into the space between the sinus floor and the Schneiderian membrane. then a combination of freeze dried bone allograft (DIZG Deutsches Institut für Zell, Germany) and PRF preparation was inserted in sinuses of the test group. The window  was covered with the membrane(Cenomembrane, Iran)  before flap closure. Intervention 2: Control group: sinus lift surgery using only allograftopen sinus lift surgery using allograft in combination of Platelet rich fibrin.  All surgery was performed with local anaesthesia, and the sinus floor augmentation using lateral window approach.  after a buccal mucoperiosteal flap was raised, an osteotomy was prepared in the lateral wall of the maxillary sinus. After the Schneiderian membrane was carefully elevated, the grafting material was packed into the space between the sinus floor and the Schneiderian membrane. then a combination of freeze dried bone allograft (DIZG Deutsches Institut für Zell, Germany) without PRF preparation was inserted in sinuses of the control group. The window  was covered with the membrane(Cenomembrane, Iran)  before flap closure.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is there is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Milad Taher</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Azadi Square., Vakilabad Blvd., Mashhad Dental Faculty</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948959</zip>
        <telephone>+98 51 3843 8962</telephone>
        <email>taher.milad@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Milad Taher</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Azadi Square., Vakilabad Blvd., Mashhad Dental Faculty</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948959</zip>
        <telephone>+98 51 3843 8962</telephone>
        <email>taher.milad@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Less than 6 mm of alveolar bone in the floor of the sinus remained
Patient 25 years old and more than
Without history of sinus lift in surgical site</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Medical contraindication for implant surgery
A history of maxillary sinus inflammations.
History of drug abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: open sinus lift surgery using allograft in combination of Platelet rich fibrin.  All surgery was performed with local anaesthesia, and the sinus floor augmentation using lateral window approach.  after a buccal mucoperiosteal flap was raised, an osteotomy was prepared in the lateral wall of the maxillary sinus. After the Schneiderian membrane was carefully elevated, the grafting material was packed into the space between the sinus floor and the Schneiderian membrane. then a combination of freeze dried bone allograft (DIZG Deutsches Institut für Zell, Germany) and PRF preparation was inserted in sinuses of the test group. The window  was covered with the membrane(Cenomembrane, Iran)  before flap closure</i_keyword>
      <i_keyword>Control group: sinus lift surgery using only allograftopen sinus lift surgery using allograft in combination of Platelet rich fibrin.  All surgery was performed with local anaesthesia, and the sinus floor augmentation using lateral window approach.  after a buccal mucoperiosteal flap was raised, an osteotomy was prepared in the lateral wall of the maxillary sinus. After the Schneiderian membrane was carefully elevated, the grafting material was packed into the space between the sinus floor and the Schneiderian membrane. then a combination of freeze dried bone allograft (DIZG Deutsches Institut für Zell, Germany) without PRF preparation was inserted in sinuses of the control group. The window  was covered with the membrane(Cenomembrane, Iran)  before flap closure</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Histomorphometric dimensions: From these primary measurements, the percentage of newly formed bone in the region of interest , the percentage of remaining bone substitute material , and the percentage of the contour length of the bone substitute material in contact with new bone (bone-to-bone substitute contact) would be calculated. Timepoint: Radiographic examination  before intervention and radiographic , histomorphometric evaluation 6 months after baseline. Method of measurement: Microscope. Photographed with a digital camera (Canon, Tokyo, Japan) mounted on a microscope ((Olympus BX51, Japan). The images will assess with the magnification of 40X.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-01-22</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Vakil Abad Blvd, Mashhad Dental Faculty Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
